Endocrinology. A prospective, randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization

By Sills E.Scott  

Human Reproduction, Vol. 14, Iss. 9, 1999-09 ,pp. : 2230-2235

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Recombinant follicle stimulating hormone in in-vitro fertilization treatment—clinical experience with follitropin alpha and follitropin beta

By Harlin Jonas   Csemiczky G.   Wramsby H.  

Human Reproduction, Vol. 15, Iss. 2, 2000-02 ,pp. : 239-244

Oxford University Press

Access to resources Recommend Favorite

A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients

By Jansen CAM  

Human Reproduction, Vol. 13, Iss. 11, 1998-11 ,pp. : 2995-2999

Oxford University Press

Access to resources Recommend Favorite

The use of a 100 IU starting dose of recombinant follicle stimulating hormone (Puregon) in in-vitro fertilization

By Devroey P  

Human Reproduction, Vol. 13, Iss. 3, 1998-03 ,pp. : 565-566

Oxford University Press

Access to resources Recommend Favorite

Endocrinology: Influence of serum follicle stimulating hormone to luteinizing hormone ratio during buserelin acetate-induced pituitary desensitizafion on ovarian response to exogenous gonadotrophins in an in-vitro fertilization and embryo transfer programme

By Yamashita Takanori   Ishimaru Tadayuki   Fujishita Akira   Kawano Masahiro   Yamabe Tooru  

Human Reproduction, Vol. 11, Iss. 8, 1996-08 ,pp. : 1615-1619

Oxford University Press

Access to resources Recommend Favorite